PDS Biotechnology (PDSB) Shares Outstanding (2014 - 2026)

PDS Biotechnology (PDSB) has 12 years of Shares Outstanding (Entity) data on file, last reported at $54.9 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 44.46% year-over-year to $54.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $54.9 million (up 44.46% YoY) and the FY2025 annual result came in at $54.9 million, up 44.46% from the prior year.
• Shares Outstanding (Entity) advanced to $54.9 million in Q4 2025, from $47.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $54.9 million in Q4 2025 to a low of $22.3 million in Q1 2021.
• A 5-year average of $34.3 million and a median of $30.9 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) soared 115.98% — and 2022, when it increased 0.08%.
• Tracing PDSB's Shares Outstanding (Entity) over 5 years: stood at $28.4 million in 2021, then gained by 6.05% to $30.2 million in 2022, then gained by 9.69% to $33.1 million in 2023, then advanced by 14.78% to $38.0 million in 2024, then surged by 44.46% to $54.9 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $54.9 million (Q4 2025), $47.7 million (Q3 2025), and $46.6 million (Q2 2025), per Business Quant data.